By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Repare Therapeutics 

7210 Frederick-Banting
Suite 100
St-Laurent  Quebec  H4S 2A1  Canada
Phone: n/a Fax: n/a


SEARCH JOBS

Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare’s platform combines a proprietary, high-throughput, CRISPR-enabled gene editing target discovery method with high-resolution protein crystallography, computational biology and clinical informatics. The company is backed by leading global healthcare investors including founding investor Versant Ventures and MPM Capital.

YEAR FOUNDED:

2016

LEADERSHIP:

Founders: Daniel Durocher, PhD., Frank Sicheri, PhD and Agnel Sfeir, PhD

President & CEO: Lloyd M. Segal

EVP, Business & Corporate Development: Kim Seth

VP, Discovery: Cameron Black

EVP, Head of R&D: Michael Zinda

CAREER:

Please click here for Repare Therapeutics' job opportunities.


Key Statistics


Email: info@reparerx.com
Ownership: Private

Web Site: Repare Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->